A normalized quality of life approach for regulatory approval of medical devices
Patient-reported outcomes (PROs) are used in clinical trials to provide valuable evidence on the impact of treatment on patients’ symptoms, function and quality of life. High-quality PRO data from trials can inform shared decisionmaking, regulatory and economic analyses and health policy. The hetero...
Saved in:
Main Authors: | Leuchter Matthias, Philipp Mark, Siewert Stefan, Schafmayer Clemens, Schmitz Klaus-Peter, Kaule Sebastian |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2024-12-01
|
Series: | Current Directions in Biomedical Engineering |
Subjects: | |
Online Access: | https://doi.org/10.1515/cdbme-2024-2104 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulatory Requirements for Medical Devices Based on Artificial Intelligence
by: Nguyen My Duyen, et al.
Published: (2024-12-01) -
Navigating regulatory and policy challenges for AI enabled combination devices
by: Snigdha Santra, et al.
Published: (2024-11-01) -
Regulatory impact assessment and “regulatory guillotine” as institutional forms of business community’s participation in the improvement of regulatory framework in Russia
by: A. A. Lialikov
Published: (2022-09-01) -
Manufacturing of porous polymer films as a basis for the novel cardiovascular implant devices
by: Reske Thomas, et al.
Published: (2024-12-01) -
Content validation of an electronic remote toxicity management system in adult patients undergoing cancer treatment: a prospective longitudinal study on the QuestOnco application
by: Raffaele Longo, et al.
Published: (2024-12-01)